MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 8, 2010, Pages 1273-1281

  Cho, William C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Biomarker; Cancer; Diagnosis; MicroRNA; Prognosis; Therapy

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; LIPOPROTEIN LIPASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RNA POLYMERASE II; STAT3 PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F5; VASCULOTROPIN; TUMOR MARKER;

ALLELE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; DNA METHYLATION; GENE TARGETING; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; ONCOGENE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROMYELOCYTIC LEUKEMIA; REVIEW; RNA BINDING; STOMACH CANCER; ANIMAL; DRUG RESISTANCE; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954386364     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.12.014     Document Type: Review

References (66)

1. Bandres E., Bitarte N., Arias F., Agorreta J., Fortes P., Agirre X., et al. MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009, 15:2281-2290.
2. Bandres E., Agirre X., Bitarte N., Ramirez N., Zarate R., Roman-Gomez J., et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009, 125:2737-2743.
3. Chen H.C., Chen G.H., Chen Y.H., Liao W.L., Liu C.Y., et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009, 100:1002-1011.
4. Childs G., Fazzari M., Kung G., Kawachi N., Brandwein-Gensler M., McLemore M., et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009, 174:736-745.
5. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007, 6:60.
6. Cho W.C. A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research. Ann Oncol 2008, 19:205-211.
7. Cho W.C. Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research. Technol Cancer Res Treat 2008, 7:269-277.
8. Cho W.C. Updates in cancer research: insights from the AACR 100th Annual Meeting. Expert Rev Mol Diagn 2009, 9:411-416.
9. Cho W.C. Role of miRNAs in lung cancer. Expert Rev Mol Diagn 2009, 9:773-776.
10. Cho W.C. MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 2010, 10.1016/j.bbcan.2009.11.003.
11. Cho W.C. Omics approaches in cancer research. An omics perspective on cancer research 2010, 1-9. Springer, New York/Berlin. W.C. Cho (Ed.).
12. Cho W.C., Chow A.S., Au J.S. Restoration of tumor suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009, 45:2197-2206.
13. Christensen B.C., Moyer B.J., Avissar M., Ouellet L.G., Plaza S.L., McClean M.D., et al. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009, 30:1003-1007.
14. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
15. De Marchis M.L., Ballarino M., Salvatori B., Puzzolo M.C., Bozzoni I., Fatica A. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 2009, 23:856-862.
16. Dyrskjøt L., Ostenfeld M.S., Bramsen J.B., Silahtaroglu A.N., Lamy P., Ramanathan R., et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009, 69:4851-4860.
17. Ebi H., Sato T., Sugito N., Hosono Y., Yatabe Y., Matsuyama Y., et al. Counterbalance between Rb inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 2009, 28:3371-3379.
18. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
19. Ferretti E., De Smaele E., Po A., Di Marcotullio L., Tosi E., Espinola M.S., et al. MicroRNA profiling in human medulloblastoma. Int J Cancer 2009, 124:568-577.
20. Friedman J.M., Liang G., Liu C.C., Wolff E.M., Tsai Y.C., Ye W., et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009, 69:2623-2629.
21. Gandellini P., Folini M., Longoni N., Pennati M., Binda M., Colecchia M., et al. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 2009, 69:2287-2295.
22. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009, 10:400-405.
23. Ghosh A.K., Shanafelt T.D., Cimmino A., Taccioli C., Volinia S., Liu C.G., et al. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009, 113:5568-5574.
24. Gibcus J.H., Tan L.P., Harms G., Schakel R.N., de Jong D., Blokzijl T., et al. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009, 11:167-176.
25. Greither T., Grochola L.F., Udelnow A., Lautenschläger C., Würl P., Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010, 126:73-80.
26. Hui A.B., Shi W., Boutros P.C., Miller N., Pintilie M., Fyles T., et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 2009, 89:597-606.
27. Hurst D.R., Edmonds M.D., Scott G.K., Benz C.C., Vaidya K.S., Welch D.R. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009, 69:1279-1283.
28. Ichimi T., Enokida H., Okuno Y., Kunimoto R., Chiyomaru T., Kawamoto K., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009, 125:345-352.
29. Ji J., Yamashita T., Budhu A., Forgues M., Jia H.L., Li C., et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009, 50:472-480.
30. Jung M., Mollenkopf H.J., Grimm C., Wagner I., Albrecht M., Waller T., et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009, 10.1111/j.1582-4934.2009.00705.
31. Kitago M., Martinez S.R., Nakamura T., Sim M.S., Hoon D.S. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res 2009, 15:2988-2994.
32. Komagata S., Nakajima M., Takagi S., Mohri T., Taniya T., Yokoi T. Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol 2009, 76:702-709.
33. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
34. Li J., Huang H., Sun L., Yang M., Pan C., Chen W., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009, 15:3998-4008.
35. Li W., Duan R., Kooy F., Sherman S.L., Zhou W., Jin P. Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet 2009, 46:358-360.
36. Li S., Fu H., Wang Y., Tie Y., Xing R., Zhu J., et al. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009, 49:1194-1202.
37. Liu M., Wu H., Liu T., Li Y., Wang F., Wan H., et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009, 19:828-837.
38. Lu L., Katsaros D., Shaverdashvili K., Qian B., Wu Y., de la Longrais I.A., et al. Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer 2009, 45:2212-2218.
39. Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., Abraham R., et al. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009, 174:1940-1948.
40. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
41. Ng E.K., Tsang W.P., Ng S.S., Jin H.C., Yu J., Li J.J., et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009, 101:699-706.
42. Nimmo R.A., Slack F.J. An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 2009, 118:405-418.
43. Noonan E.J., Place R.F., Pookot D., Basak S., Whitson J.M., Hirata H., et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009, 28:1714-1724.
44. Pan Y.Z., Morris M.E., Yu A.M. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009, 75:1374-1379.
45. Pigazzi M., Manara E., Baron E., Basso G. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 2009, 69:2471-2478.
46. Popovic R., Riesbeck L.E., Velu C.S., Chaubey A., Zhang J., Achille N.J., et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009, 113:3314-3322.
47. Rahman M.M., Qian Z.R., Wang E.L., Sultana R., Kudo E., Nakasono M., et al. Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumors and its relationship to let-7 downregulation. Br J Cancer 2009, 100:501-510.
48. Reddy S.D., Pakala S.B., Ohshiro K., Rayala S.K., Kumar R., MicroRNA-661 a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Res 2009, 69:5639-5642.
49. Roccaro A.M., Sacco A., Thompson B., Leleu X., Azab A.K., Azab F., et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 2009, 113:6669-6680.
50. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
51. Siva A.C., Nelson L.J., Fleischer C.L., Majlessi M., Becker M.M., Vessella R.L., et al. Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer 2009, 8:17.
52. Spahn M., Kneitz S., Scholz C.J., Nico S., Rüdiger T., Ströbel P., et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 2009, 10.1002/ijc.24715.
53. Stamatopoulos B., Meuleman N., Haibe-Kains B., Saussoy P., Van Den Neste E., Michaux L, et al. MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009, 113:5237-5245.
54. Taulli R., Bersani F., Foglizzo V., Linari A., Vigna E., Ladanyi M., et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009, 119:2366-2378.
55. Tömböl Z., Szabó P., Molnár V., Wiener Z., Tölgyesi G., Horànyi J., et al. Integrative molecular-bioinformatics study of human adrenocortical tumors: microRNA, tissue specific target prediction and pathway analysis. Endocr Relat Cancer 2009, 16:895-906.
56. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009, 49:1571-1582.
57. Veerla S., Lindgren D., Kvist A., Frigyesi A., Staaf J., Persson H., et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 2009, 124:2236-2242.
58. Wang Y., Rathinam R., Walch A., Alahari S.K. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009, 284:23094-23106.
59. Wu F., Zhu S., Ding Y., Beck W.T., Mo Y.Y. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res 2009, 15:1550-1557.
60. Xi Y., Nakajima G., Gavin E., Morris C.G., Kudo K., Hayashi K., et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13:1668-1674.
61. Xu H., Cheung I.Y., Guo H.F., Cheung N.K. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 2009, 69:6275-6281.
62. Yang Y., Chaerkady R., Beer M.A., Mendell J.T., Pandey A. Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009, 9:1374-1384.
63. Yin J.Q., Zhao R.C., Morris K.V. Profiling microRNA expression with microarrays. Trends Biotechnol 2008, 26:70-76.
64. Zenz T., Mohr J., Eldering E., Kater A.P., Bühler A., Kienle D., et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009, 113:3801-3808.
65. Zhang X., Liu S., Hu T., Liu S., He Y., Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499.
66. Zhu J.Y., Pfuhl T., Motsch N., Barth S., Nicholls J., Grässer F., et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009, 83:3333-3341.